Interaction Checker

Add peptides or compounds to check all pairwise interactions, cumulative organ load, and safety flags.

This stack looks good: 1 synergistic interaction(s) found. No conflicts detected.

Cumulative Organ Load

Heart
low

Shared Safety Flags

2x 2 hepatotoxic compounds (Ezetimibe, Pitavastatin). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 compounds disrupt lipids (Ezetimibe, Pitavastatin). Get lipid panel mid-cycle — consider adding lipid support.
2x 2 compounds share the teratogenic safety flag (Ezetimibe, Pitavastatin). Monitor accordingly.
++
Ezetimibe + Pitavastatin
Synergistic

Pitavastatin and ezetimibe act on complementary cholesterol pathways — pitavastatin inhibits hepatic synthesis while ezetimibe blocks intestinal absorption. The combination provides an additional 15-20% LDL reduction beyond pitavastatin monotherapy. This pairing preserves pitavastatin's low interaction profile since ezetimibe is also minimally metabolized by CYP enzymes. Particularly useful for AAS users who need greater LDL reduction without switching to a higher-interaction statin.

Researched 95% confidence Compare

Interaction data is compiled from research literature, pharmacological analysis, and community reports. Inferred interactions are based on known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.